UK Life Sciences Product & Service Launches
Products and services news follows new and materially improved commercial offerings from UK life sciences companies. It covers tools and services used in research, development, diagnostics, manufacturing and scientific operations.
Inovia Bio Launches InovaMine Biostatistics and Reporting Software
Inovia Bio has made InovaMine available as a standalone software product for biostatistics and clinical-data reporting. The platform takes datasets and statistical analysis plans, generates tables, listings and figures, and links reported results back to source records for traceability. According to the company, statistical outputs are reviewed and signed off by a statistician before release.
Hikma Launches NPH Otic Solution in US with Orbicular Partnership
Hikma Pharmaceuticals has launched a sterile generic ear-drop treatment containing neomycin, polymyxin B and hydrocortisone in the United States. The product was developed by Orbicular Pharmaceutical Technologies, which holds the abbreviated new drug application, while Hikma will commercialise and distribute it. The medicine has FDA approval as a Competitive Generic Therapy for certain bacterial infections of the external ear. The announcement does not establish UK marketing approval.
Cell Guidance Systems Launches Automated EVlution Pro TFF Systems
Cell Guidance Systems has launched EVlution Pro, a benchtop tangential-flow filtration system for concentrating and exchanging buffers in samples containing extracellular vesicles, proteins and other biomolecules. Two models are available: Pro 1 provides basic monitoring, while Pro 3 adds balances, pressure and temperature sensors with automated data logging. Orders are open. The launch extends its existing EVlution cartridge range rather than introducing filtration technology for the first time.
OGT Launches First Dedicated Fusion MRD NGS Panel for AML
OGT has launched the SureSeq myPanel Myeloid Fusion MRD Panel, which it describes as the first dedicated next-generation sequencing panel for detecting AML fusion events at measurable residual disease sensitivity. The research-use panel was developed with Roswell Park Comprehensive Cancer Center and can be run alongside OGT's Myeloid MRD Plus panel.
REPROCELL Launches REPROSKIN Human Skin Model as Both a Research Product and Contract Testing Service
REPROCELL has launched REPROSKIN, a full-thickness human skin model built from primary keratinocytes and fibroblasts grown in its Alvetex scaffold and developed with Durham University. It is available through REPROCELL Europe both as live tissue for researchers to use in their own labs and as a fee-for-service testing offering run by REPROCELL scientists.